Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Pediatric Endocrinology · 21-Hydroxylase-Deficiency Congenital Adrenal Hyperplasia

How Is Salt-Wasting CAH Diagnosed vs Simple-Virilizing CAH?

At a Glance

Salt-wasting and simple-virilizing classic CAH can look alike at birth. Doctors distinguish them by repeated checks of sodium, potassium, renin, hydration, weight, and symptoms over the first weeks; genetic testing can help but does not replace this monitoring.

Doctors distinguish between the two types of classic 21-hydroxylase-deficiency CAH by closely monitoring a baby’s clinical health and blood chemistry over time, sometimes aided by genetic testing. In salt-wasting (SW) CAH, the adrenal glands cannot produce enough aldosterone (a hormone that retains salt) [1][2]. In simple-virilizing (SV) CAH, the body produces enough aldosterone to maintain salt balance on its own [1].

Importantly, both subtypes are on a severity spectrum, and both involve a deficiency in cortisol that requires specialist care [3]. The main treatment difference is that babies with SW CAH typically require extra treatment with fludrocortisone and oral salt supplements to prevent severe dehydration and electrolyte imbalance [3][4].

The Diagnostic Process

An abnormal newborn screening result is not a confirmed diagnosis; false positives can happen, especially in premature or medically stressed infants [5][6]. When classic CAH is suspected, pediatric endocrinologists will evaluate the baby to confirm the diagnosis and determine the specific subtype. Because the two subtypes can look physically identical at birth and both cause high levels of hormones like 17-hydroxyprogesterone (17-OHP) and androgens, doctors cannot rely on these markers alone to tell them apart [7][8]. Instead, they rely on a longitudinal assessment of the baby’s electrolytes, weight, hydration, and overall clinical course over the first weeks of life [3].

Monitoring Blood Chemistry

Subtype classification is based on observing how the baby’s body regulates electrolytes over time, interpreted using age-appropriate reference ranges. A single normal blood panel does not rule out salt-wasting CAH, as electrolyte imbalances may take days or weeks to develop [6][9]. Doctors monitor:

  • Sodium and Potassium: In SW CAH, without enough aldosterone, sodium levels eventually drop (hyponatremia) and potassium levels rise (hyperkalemia) [10][9].
  • Plasma Renin Activity: Renin is an enzyme released when blood volume or sodium is low. In SW CAH, renin levels become elevated—often before sodium drops—as the body attempts to signal for more salt retention [7][9]. Because renin levels are naturally higher in all newborns, results must be carefully compared to neonatal averages.
  • Acid-Base Balance: SW CAH can lead to metabolic acidosis, meaning the blood has lower levels of bicarbonate [10][9].

The Role of Genetic Testing

To help clarify the diagnosis or for family planning, doctors may order genetic testing of the CYP21A2 gene [11][12]. The specific combination of mutations can help predict severity:

  • Severe Mutations: “Null” or “Group A” mutations result in little to no enzyme function. Having two of these is strongly associated with salt-wasting CAH [11].
  • Milder Mutations: Variants like the I172N mutation retain slight enzyme function and are most commonly associated with simple-virilizing CAH [12].

However, genetic testing is not perfectly predictive. Genotype-phenotype discordance can occur, meaning the disease severity does not perfectly match what the genes predict [12][13]. Some variants, such as the intron 2 splice variant (c.293-13A/C>G, often called “In2G”), are highly variable and can lead to either subtype [14]. Because of this, treatment decisions should be based on the baby’s actual clinical and biochemical health, not on genetics alone [4].

Treatment and Emergency Planning

Because both subtypes feature cortisol deficiency, treatment often begins with glucocorticoid replacement (like hydrocortisone) while monitoring continues [3]. If SW CAH is suspected or confirmed, fludrocortisone and oral salt are added [3][4]. Parents should never start, stop, or adjust these medications without the endocrinology team’s instructions.

During this evaluation period, babies are at risk for an adrenal crisis, a life-threatening emergency triggered by cortisol and aldosterone deficiency during illness or physical stress [10][3].

Warning signs of an evolving adrenal crisis include:

  • Repeated vomiting or inability to keep feeds or medicines down
  • Extreme sleepiness, lethargy, or weakness
  • Poor responsiveness or low muscle tone
  • Pale skin or severe dehydration

Emergency Action: If you suspect an adrenal crisis or your baby shows these signs, do not wait for repeat lab results. Follow your clinician-provided sick-day or emergency-injection plan immediately and seek emergency medical care or call emergency services right away [9][15].

Common questions in this guide

How do doctors tell salt-wasting CAH from simple-virilizing CAH?
Doctors use the baby's changing blood chemistry and clinical health rather than one test. Salt-wasting CAH may cause sodium to fall, potassium to rise, renin to increase, and bicarbonate to fall, while simple-virilizing CAH usually maintains salt balance. Both forms can look alike at birth and can have high 17-hydroxyprogesterone and androgen levels.
Can one normal electrolyte test rule out salt-wasting CAH?
No. Salt-wasting changes may take days or weeks to appear, and renin can rise before sodium falls. Doctors repeat age-appropriate blood tests while monitoring the baby's weight, hydration, and symptoms.
What can genetic testing show about the type of classic CAH?
Genetic testing examines the CYP21A2 gene and can help estimate whether the enzyme deficiency is more severe. Two severe or “null” variants are strongly associated with salt-wasting CAH, while the I172N variant is more often linked with simple-virilizing CAH. Results are not perfect, so the baby's actual laboratory findings and health guide treatment.
Does an abnormal newborn screen confirm classic CAH?
An abnormal newborn screen is a warning that needs follow-up, not a confirmed diagnosis. False-positive results are more common in premature or medically stressed infants. A pediatric endocrinologist confirms classic CAH using the baby's clinical course, blood chemistry, and sometimes genetic testing.
What treatment may my baby receive while the CAH subtype is being clarified?
Because both forms cause cortisol deficiency, doctors often start glucocorticoid replacement such as hydrocortisone while evaluation continues. If salt-wasting CAH is suspected or confirmed, fludrocortisone and oral salt supplements may be added. Parents should not start, stop, or change these medicines without the endocrinology team's instructions.
What symptoms could mean my baby is having an adrenal crisis?
Repeated vomiting or inability to keep feeds or medicine down, extreme sleepiness, weakness, poor responsiveness, low muscle tone, pallor, or severe dehydration can signal an adrenal crisis. Follow the clinician-provided sick-day or emergency-injection plan immediately and seek emergency care or call emergency services. Do not wait for repeat laboratory results.

Get notified when new evidence is published on Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    Severe Hyperandrogenism in 46,XX Congenital Adrenal Hyperplasia: Molecular Physiopathology, Late Diagnoses, and Personalized Management.

    Cera G, Corsello A, Novizio R, et al.

    International journal of molecular sciences 2024; (25(21)) doi:10.3390/ijms252111779.

    PMID: 39519330
  2. 2

    Analysis of phenotypes and genotypes in 84 patients with 21-Hydroxylase deficiency in southern China.

    Hou L, Liang L, Lin S, et al.

    Steroids 2019; (151()):108474 doi:10.1016/j.steroids.2019.108474.

    PMID: 31446012
  3. 3

    Treatment and Follow-up of Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency in Childhood and Adolescence

    Peltek Kendirci HN, Ünal E, Dündar İ, et al.

    Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):12-22 doi:10.4274/jcrpe.galenos.2024.2024-6-26-S.

    PMID: 39713876
  4. 4

    Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure.

    Neumann U, van der Linde A, Krone RE, et al.

    European journal of endocrinology 2022; (186(5)):587-596 doi:10.1530/EJE-21-1085.

    PMID: 35290211
  5. 5

    Four Consecutive False Negative Newborn Screens in a Patient with Classical Congenital Adrenal Hyperplasia: A Case Report

    Rizzuto P, Gangat M, Khattab A, Marshall I

    Journal of clinical research in pediatric endocrinology 2026; (18(Suppl 1)):92-96 doi:10.4274/jcrpe.galenos.2025.2024-10-16.

    PMID: 41797552
  6. 6

    Characteristics of Patients with Classic Congenital Adrenal Hyperplasia Missed on the Newborn Screen.

    Saroufim R, Nebesio TD, Eugster EA

    Hormone research in paediatrics 2024; (97(5)):470-476 doi:10.1159/000535405.

    PMID: 37992692
  7. 7

    Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.

    Liu SY, Lee CT, Tung YC, et al.

    Journal of the Formosan Medical Association = Taiwan yi zhi 2018; (117(2)):126-131 doi:10.1016/j.jfma.2017.03.008.

    PMID: 28392195
  8. 8

    Vaginal bleeding and a giant ovarian cyst in an infant with 21-hydroxylase deficiency.

    Şahin NM, Bayramoğlu E, Çetinkaya S, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2018; (31(2)):229-233 doi:10.1515/jpem-2017-0235.

    PMID: 29252197
  9. 9

    Congenital Adrenal Hyperplasia-When Clinical Symptoms Are Missing.

    Ferraz Liz C, Rocha A

    Pediatric emergency care 2021; (37(10)):e666-e668 doi:10.1097/PEC.0000000000001752.

    PMID: 30855422
  10. 10

    Congenital adrenal hyperplasia with salt-wasting crisis and arrhythmia: a case study.

    Canlas JF, Ponmani C

    BMJ case reports 2019; (12(1)) doi:10.1136/bcr-2018-227565.

    PMID: 30700462
  11. 11

    Genotype/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients.

    Riedl S, Röhl FW, Bonfig W, et al.

    Endocrine connections 2019; (8(2)):86-94.

    PMID: 30620712
  12. 12

    Clinical and Biochemical Phenotype Across the Genotypic Spectrum of 21-hydroxylase Deficiency in 457 Individuals.

    Lao Q, Schulman A, Kulkarni S, et al.

    The Journal of clinical endocrinology and metabolism 2026; (111(4)):1098-1113 doi:10.1210/clinem/dgaf546.

    PMID: 41051294
  13. 13

    Accurate diagnosis of congenital adrenal hyperplasia due to CYP21A2 variants requires promoter analysis.

    Schernthaner-Reiter MH, Riedl S, Obermayer-Pietsch B, et al.

    European journal of endocrinology 2025; (193(5)):663-674 doi:10.1093/ejendo/lvaf217.

    PMID: 41109685
  14. 14

    Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

    Kocova M, Concolino P, Falhammar H

    Frontiers in endocrinology 2021; (12()):788812 doi:10.3389/fendo.2021.788812.

    PMID: 35140681
  15. 15

    Congenital Adrenal Hyperplasia.

    Fraga NR, Minaeian N, Kim MS

    Pediatrics in review 2024; (45(2)):74-84 doi:10.1542/pir.2022-005617.

    PMID: 38296783

This page is for informational purposes only and does not constitute medical advice. Your baby's pediatric endocrinology team should interpret test results and direct medication, monitoring, and emergency care.